GRP94 (gp96) and GRP94 N-Terminal Geldanamycin Binding Domain Elicit Tissue Nonrestricted Tumor Suppression

In chemical carcinogenesis models, GRP94 (gp96) elicits tumor-specific protective immunity. The tumor specificity of this response is thought to reflect immune responses to GRP94-bound peptide antigens, the cohort of which uniquely identifies the GRP94 tissue of origin. In this study, we examined th...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker-LePain, Julie C., Sarzotti, Marcella, Fields, Timothy A., Li, Chuan-Yuan, Nicchitta, Christopher V.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2002
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194266/
https://www.ncbi.nlm.nih.gov/pubmed/12461080
http://dx.doi.org/10.1084/jem.20020436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194266/
https://www.ncbi.nlm.nih.gov/pubmed/12461080
http://dx.doi.org/10.1084/jem.20020436

Ejemplares similares